Month: October 2021

Researchers report that a recently discovered inflammatory mediator, interleukin-26, appears to have an important role in pneumonia and contribute to the killing of bacteria.

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say researchers. This could affect responses to secondary infections.

Scientists are using a mathematical model to better understand the immune response to vaccines.

Researchers look at the use of intravenous immunoglobulin for treatment of Kawasaki disease and multisystem inflammatory syndrome in children, a rare reaction to SARS-CoV-2.

Researchers describe how malignancies leverage evolution and basic cellular functions to promote immune dysfunction and a better future for themselves.

Researchers have revealed in an animal model that ImmuBalance, a fermented soybean product, is effective in suppressing airway inflammation caused by asthma. Results showed a decreased presence of eosinophils in bronchoalveolar lavage fluid, a decrease…

Researchers have found a way to make antibiotics more effective against antibiotic-resistant bacteria – also known as ‘superbugs.

Interleukin-12 — a messenger molecule of immune cells — was long considered to trigger the development of psoriasis. Now, researchers have shown that interleukin-12 does not actually cause the skin disease but protects against it. This also explains …

Using a novel technology, researchers uncovered shape-shifting properties of a common respiratory virus.

In evolutionary biology, the ‘Life History Theory,’ first proposed in the 1950s, postulates that when the environment is favorable, the resources used by any organism are devoted for growth and reproduction. Conversely, in a hostile environment, resour…